about
Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients.The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage.MRI-detection rate and incidence of lumbar bleeding sources in 190 patients with non-aneurysmal SAH.Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels?Aneurysm-related subarachnoid hemorrhage and acute subdural hematoma: single-center series and systematic review.Endovascular and surgical treatment of internal carotid bifurcation aneurysms: comparison of results, outcome, and mid-term follow-up.Non-aneurysmal non-perimesencephalic subarachnoid hemorrhage: effect of rehabilitation at short-term and in a prospective study of long-term follow-up.Cerebral Vasospasm-Dependent and Cerebral Vasospasm-Independent Cerebral Infarctions Predict Outcome After Nonaneurysmal Subarachnoid Hemorrhage: A Single-Center Series with 250 Patients.Outcome After Subarachnoid Hemorrhage from Blood Blister-Like Aneurysm Rupture Depends on Age and Aneurysm Morphology.Outcome after Hunt and Hess Grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980-1995) versus post-ISAT era (2005-2014).Optimization of the Surgical Approach in AVMs Using MRI and 4D DSA Fusion Technique : A technical note.Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.Cerebral foreign body granuloma in brain triggering generalized seizures without obvious craniocerebral injury: A case report and review of the literature.Outcome and prognostic factors after delayed second subarachnoid haemorrhage.Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional 'H' therapy in vasospasm treatment.Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model.Cerebral vasospasm and delayed cerebral infarctions in 225 patients with non-aneurysmal subarachnoid hemorrhage: the underestimated risk of Fisher 3 blood distribution.Clinical outcome and prognostic factors of patients with angiogram-negative and non-perimesencephalic subarachnoid hemorrhage: benign prognosis like perimesencephalic SAH or same risk as aneurysmal SAH?Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor?Evaluation of the perforators of the anterior communicating artery (AComA) using routine cerebral 3D rotational angiography.Outcome of Patients with Long-Lasting Cerebral Vasospasm After Subarachnoid Hemorrhage: Is Prolonged Treatment for Cerebral Vasospasm Worthwhile? A Matched-Pair Analysis.Rapid ventricular pacing for clip reconstruction of complex unruptured intracranial aneurysms: results of an interdisciplinary prospective trial.The Impact of Tracheostomy Timing on Clinical Outcome and Adverse Events in Poor-Grade Subarachnoid Hemorrhage.Crosstalk between the angiotensin and endothelin-system in the cerebrovasculature.The impact of the body mass index on outcome after subarachnoid hemorrhage: is there an obesity paradox in SAH? A retrospective analysis.Frequency, risk of hemorrhage and treatment considerations for cerebral arteriovenous malformations with associated aneurysms.General Anesthesia Versus Local Anesthesia in Stereotactic Biopsies of Brain Lesions: A Prospective Randomized Study.Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.Epileptic Seizures in Patients Following Surgical Treatment of Acute Subdural Hematoma-Incidence, Risk Factors, Patient Outcome, and Development of New Scoring System for Prophylactic Antiepileptic Treatment (GATE-24 score).Significant increase in acute subdural hematoma in octo- and nonagenarians: surgical treatment, functional outcome, and predictors in this patient cohort.Non-aneurysmal subarachnoid hemorrhage in 173 patients: a prospective study of long-term outcome.Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.Functional effects of levosimendan in rat basilar arteries in vitro.Outcome, Prognostic Factors, and Follow-Up Results After Subarachnoid Hemorrhage from Pericallosal Artery Aneurysms.Aneurysm Location as a Prognostic Outcome Factor After Subarachnoid Hemorrhage From Internal Carotid Artery Aneurysms and Potential Impact for Further Experimental Subarachnoid Hemorrhage Models.Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.Influence of ABO blood type on the outcome after non-aneurysmal subarachnoid hemorrhage.Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage.
P50
Q33870036-F4A59B18-BD51-44B4-B55C-FD2D85E30F4FQ36173543-1DE988B4-FE18-4527-A613-70978821123DQ36331814-9ACBEE39-3A23-45DF-B9DB-03D963B9F122Q37813519-B15098FC-C2EC-4356-A685-C170725E1EA9Q38071689-E0C7ED6A-9333-44BB-973F-D44CB757CA5AQ38337663-82E0B401-09F0-4BFA-A08D-A8304D241A48Q38395444-A6554CBF-D2A3-424D-9B58-797D5F99B52AQ38677468-34A56499-8AA7-4C81-9DD0-457C8DC6E5A3Q38699414-597D33AD-C85A-4F7B-A6D5-E133E0161442Q38905425-CF4B5A04-D96C-41D4-A6BE-EA518AD43DE2Q38910142-C1730BA0-7CED-4AFD-8A76-39D3348BFC09Q38926867-F099DE19-2962-47F4-B972-695F16CEFCF8Q39030230-A3649A72-1DAB-43D2-A2A7-BC438DC641C7Q39109178-08163DC1-CA79-4334-9976-5ACDF1DF411EQ39116491-8D0DF93D-7C16-411D-BB8E-95B89759F692Q39253266-11A0943B-7A14-4D59-B32A-E8059ED25B0DQ39403989-179C5E07-76E6-45C0-9057-D5E162B1D437Q39756514-8B5377B7-5343-4295-8A6C-7FAA5CCA40D2Q40022149-2CAB83F7-ADB3-4F0C-893A-9E6676CBE9DBQ40219518-73B1C313-835F-41DA-BC02-B745F524918EQ40323882-AFC62CE5-DA12-408B-94D3-F33A3DFB900FQ40358489-ECBAF355-EFAB-4211-AFEA-5946A7FCCF4EQ40396270-2B27264A-1455-46DA-B446-455038504A12Q40497075-E043AFF2-1E72-48E1-B4AE-2F79BD2D5093Q40606215-1A9AB349-7C3E-4C9A-B7BE-9963232DCDBCQ44971793-D40AFBEF-A6E1-4358-A310-97804E9B2863Q45327413-B2565729-0024-4760-A572-B2C70246E18BQ46313510-B4D67685-FA19-4C85-86F1-A3DF7B259438Q47384643-29BA3A14-0A0C-4D3F-B86B-83FA2BB2CCE0Q47727132-A96CB21C-CDCE-4B29-B272-E53F45C727F6Q47967378-595677B3-9E5B-49C6-BB78-1CA825051FEBQ47992973-6393EEB7-1B40-4BEC-95B6-557E0BC3BDFEQ48020903-4E764DAE-1312-48EB-B7E2-0A3BE635A7D1Q48056900-C4A39EEB-6658-4E78-A11A-C83E90676698Q48135430-D2609DA5-DA32-4995-BE90-756F57B22E24Q48377806-DC9F72E7-88F5-48AA-865E-87AE86382D35Q48764329-804E16CA-8105-406A-880A-FAB5600C4895Q49028052-4F4743EB-39B0-4A2E-8E5D-6E9DDD004567Q49891141-D33DF44B-C641-4F84-B809-B81A0E219C9FQ50041701-99E11689-94B2-4C66-A05E-834E3E944E0E
P50
description
onderzoeker
@nl
researcher ORCID id 0000-0001-9771-7806
@en
name
Juergen Konczalla
@ast
Juergen Konczalla
@en
Juergen Konczalla
@es
Juergen Konczalla
@nl
type
label
Juergen Konczalla
@ast
Juergen Konczalla
@en
Juergen Konczalla
@es
Juergen Konczalla
@nl
prefLabel
Juergen Konczalla
@ast
Juergen Konczalla
@en
Juergen Konczalla
@es
Juergen Konczalla
@nl
P214
P106
P1153
14007982300
P214
P31
P3835
juergen-konczalla2
P496
0000-0001-9771-7806
P7859
viaf-149697537